PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Pharmacist Culture Review in Urgent Care: Two Hours Faster, Similar Revisits

★ Editor's Pickpharmacist-driven microbiology reviewurgent careantimicrobial stewardshipculture follow-upcollaborative practice agreementurinary tract infectionskin and soft tissue infectionsexually transmitted infectionsretrospective cohortoutpatient stewardship Infectious Disease / Antimicrobials

Background Information

Pharmacists speed up urgent care treatment decisions by 2 hours.

Pharmacist-driven microbiology review programs can potentially improve antimicrobial treatment in urgent care settings. The program reduced the time to appropriate treatment by 2 hours compared to physician-only reviews (11 hours vs 13 hours, p = 0.047), with similar unplanned 30-day revisit rates. This study supports integrating pharmacists into urgent care teams to enhance timely treatment; however, the difference was small and revisit rates were unchanged. Pharmacist-driven reviews may marginally speed up appropriate treatment without impacting revisit rates.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Bomkamp JP, Craft BV, Nuest H, Bjornstad M, Slavens J

Citation: Bomkamp JP, Craft BV, Nuest H, et al. A Retrospective Evaluation of a Pharmacist-Driven Urgent Care Microbiology Review Program. Journal of the American College of Clinical Pharmacy : JACCP. 2026;9(8):e70262. doi:10.1002/jac5.70262

Article Links: PubMed · Journal / DOI

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.